Viewing Study NCT07486895


Ignite Creation Date: 2026-03-26 @ 3:14 PM
Ignite Modification Date: 2026-03-30 @ 3:15 AM
Study NCT ID: NCT07486895
Status: COMPLETED
Last Update Posted: 2026-03-23
First Post: 2026-03-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Trial to Demonstrate the Equivalence of Two Different Strengths of Oral Centanafadine Capsules in Healthy Subjects
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2023-03-08
Start Date Type: ACTUAL
Primary Completion Date: 2023-05-18
Primary Completion Date Type: ACTUAL
Completion Date: 2023-05-18
Completion Date Type: ACTUAL
First Submit Date: 2026-03-17
First Submit QC Date: None
Study First Post Date: 2026-03-23
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2026-03-17
Last Update Post Date: 2026-03-23
Last Update Post Date Type: ACTUAL